The polycomb group protein L3MBTL1 repreßes a SMAD5-mediated hematopoietic transcriptional program in human pluripotent stem cells

Fabiana Perna, Ly P. Vu, Maria Themeli, Sonja Kriks, Ruben Hoya-Arias, Raya Khanin, Todd Hricik, Jorge Mansilla-Soto, Eirini P. Papapetrou, Roß L. Levine, Lorenz Studer, Michel Sadelain, Stephen D Nimer

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Epigenetic regulation of key transcriptional programs is a critical mechanism that controls hematopoietic development, and, thus, aberrant expression patterns or mutations in epigenetic regulators occur frequently in hematologic malignancies. We demonstrate that the Polycomb protein L3MBTL1, which is monoallelically deleted in 20q- myeloid malignancies, represses the ability of stem cells to drive hematopoietic-specific transcriptional programs by regulating the expression of SMAD5 and impairing its recruitment to target regulatory regions. Indeed, knockdown of L3MBTL1 promotes the development of hematopoiesis and impairs neural cell fate in human pluripotent stem cells. We also found a role for L3MBTL1 in regulating SMAD5 target gene expression in mature hematopoietic cell pop-ulations, thereby affecting erythroid differentiation. Taken together, we have identified epigenetic priming of hematopoietic-specific transcriptional networks, which may assist in the development of therapeutic approaches for patients with anemia.

Original languageEnglish (US)
Pages (from-to)658-669
Number of pages12
JournalStem Cell Reports
Volume4
Issue number4
DOIs
StatePublished - 2015

Fingerprint

Polycomb-Group Proteins
Pluripotent Stem Cells
Stem cells
Epigenomics
Nucleic Acid Regulatory Sequences
Gene expression
Gene Regulatory Networks
Hematopoiesis
Hematologic Neoplasms
Anemia
Stem Cells
Gene Expression
Mutation
Proteins
Neoplasms
Therapeutics

ASJC Scopus subject areas

  • Biochemistry
  • Cell Biology
  • Developmental Biology
  • Genetics

Cite this

The polycomb group protein L3MBTL1 repreßes a SMAD5-mediated hematopoietic transcriptional program in human pluripotent stem cells. / Perna, Fabiana; Vu, Ly P.; Themeli, Maria; Kriks, Sonja; Hoya-Arias, Ruben; Khanin, Raya; Hricik, Todd; Mansilla-Soto, Jorge; Papapetrou, Eirini P.; Levine, Roß L.; Studer, Lorenz; Sadelain, Michel; Nimer, Stephen D.

In: Stem Cell Reports, Vol. 4, No. 4, 2015, p. 658-669.

Research output: Contribution to journalArticle

Perna, F, Vu, LP, Themeli, M, Kriks, S, Hoya-Arias, R, Khanin, R, Hricik, T, Mansilla-Soto, J, Papapetrou, EP, Levine, RL, Studer, L, Sadelain, M & Nimer, SD 2015, 'The polycomb group protein L3MBTL1 repreßes a SMAD5-mediated hematopoietic transcriptional program in human pluripotent stem cells', Stem Cell Reports, vol. 4, no. 4, pp. 658-669. https://doi.org/10.1016/j.stemcr.2015.02.003
Perna, Fabiana ; Vu, Ly P. ; Themeli, Maria ; Kriks, Sonja ; Hoya-Arias, Ruben ; Khanin, Raya ; Hricik, Todd ; Mansilla-Soto, Jorge ; Papapetrou, Eirini P. ; Levine, Roß L. ; Studer, Lorenz ; Sadelain, Michel ; Nimer, Stephen D. / The polycomb group protein L3MBTL1 repreßes a SMAD5-mediated hematopoietic transcriptional program in human pluripotent stem cells. In: Stem Cell Reports. 2015 ; Vol. 4, No. 4. pp. 658-669.
@article{0254b14880514a22abb3bc2b3e3d1c2e,
title = "The polycomb group protein L3MBTL1 repre{\ss}es a SMAD5-mediated hematopoietic transcriptional program in human pluripotent stem cells",
abstract = "Epigenetic regulation of key transcriptional programs is a critical mechanism that controls hematopoietic development, and, thus, aberrant expression patterns or mutations in epigenetic regulators occur frequently in hematologic malignancies. We demonstrate that the Polycomb protein L3MBTL1, which is monoallelically deleted in 20q- myeloid malignancies, represses the ability of stem cells to drive hematopoietic-specific transcriptional programs by regulating the expression of SMAD5 and impairing its recruitment to target regulatory regions. Indeed, knockdown of L3MBTL1 promotes the development of hematopoiesis and impairs neural cell fate in human pluripotent stem cells. We also found a role for L3MBTL1 in regulating SMAD5 target gene expression in mature hematopoietic cell pop-ulations, thereby affecting erythroid differentiation. Taken together, we have identified epigenetic priming of hematopoietic-specific transcriptional networks, which may assist in the development of therapeutic approaches for patients with anemia.",
author = "Fabiana Perna and Vu, {Ly P.} and Maria Themeli and Sonja Kriks and Ruben Hoya-Arias and Raya Khanin and Todd Hricik and Jorge Mansilla-Soto and Papapetrou, {Eirini P.} and Levine, {Ro{\ss} L.} and Lorenz Studer and Michel Sadelain and Nimer, {Stephen D}",
year = "2015",
doi = "10.1016/j.stemcr.2015.02.003",
language = "English (US)",
volume = "4",
pages = "658--669",
journal = "Stem Cell Reports",
issn = "2213-6711",
publisher = "Cell Press",
number = "4",

}

TY - JOUR

T1 - The polycomb group protein L3MBTL1 repreßes a SMAD5-mediated hematopoietic transcriptional program in human pluripotent stem cells

AU - Perna, Fabiana

AU - Vu, Ly P.

AU - Themeli, Maria

AU - Kriks, Sonja

AU - Hoya-Arias, Ruben

AU - Khanin, Raya

AU - Hricik, Todd

AU - Mansilla-Soto, Jorge

AU - Papapetrou, Eirini P.

AU - Levine, Roß L.

AU - Studer, Lorenz

AU - Sadelain, Michel

AU - Nimer, Stephen D

PY - 2015

Y1 - 2015

N2 - Epigenetic regulation of key transcriptional programs is a critical mechanism that controls hematopoietic development, and, thus, aberrant expression patterns or mutations in epigenetic regulators occur frequently in hematologic malignancies. We demonstrate that the Polycomb protein L3MBTL1, which is monoallelically deleted in 20q- myeloid malignancies, represses the ability of stem cells to drive hematopoietic-specific transcriptional programs by regulating the expression of SMAD5 and impairing its recruitment to target regulatory regions. Indeed, knockdown of L3MBTL1 promotes the development of hematopoiesis and impairs neural cell fate in human pluripotent stem cells. We also found a role for L3MBTL1 in regulating SMAD5 target gene expression in mature hematopoietic cell pop-ulations, thereby affecting erythroid differentiation. Taken together, we have identified epigenetic priming of hematopoietic-specific transcriptional networks, which may assist in the development of therapeutic approaches for patients with anemia.

AB - Epigenetic regulation of key transcriptional programs is a critical mechanism that controls hematopoietic development, and, thus, aberrant expression patterns or mutations in epigenetic regulators occur frequently in hematologic malignancies. We demonstrate that the Polycomb protein L3MBTL1, which is monoallelically deleted in 20q- myeloid malignancies, represses the ability of stem cells to drive hematopoietic-specific transcriptional programs by regulating the expression of SMAD5 and impairing its recruitment to target regulatory regions. Indeed, knockdown of L3MBTL1 promotes the development of hematopoiesis and impairs neural cell fate in human pluripotent stem cells. We also found a role for L3MBTL1 in regulating SMAD5 target gene expression in mature hematopoietic cell pop-ulations, thereby affecting erythroid differentiation. Taken together, we have identified epigenetic priming of hematopoietic-specific transcriptional networks, which may assist in the development of therapeutic approaches for patients with anemia.

UR - http://www.scopus.com/inward/record.url?scp=84933673346&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84933673346&partnerID=8YFLogxK

U2 - 10.1016/j.stemcr.2015.02.003

DO - 10.1016/j.stemcr.2015.02.003

M3 - Article

C2 - 25754204

AN - SCOPUS:84933673346

VL - 4

SP - 658

EP - 669

JO - Stem Cell Reports

JF - Stem Cell Reports

SN - 2213-6711

IS - 4

ER -